Article
The genetic basis of inhibitor development in haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia - 1 Jul 1998
Tuddenham E G, McVey J H
Abstract excerpt
Inhibitor development is now the main complication of replacement therapy in haemophilia A. Given that most severely affected patients make no detectable factor VIII, it is perhaps surprising that only approximately 30% actually mount an immune response to factor VIII as a foreign antigen. Those that do mostly have major factor VIII gene lesions. The association of HLA genotype with inhibitors in patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.